Regulation & Compliance

A new partnership brings mask-free sleep apnea therapy to veterans, aligning with updated DoD/VA guidelines that prioritize patient preference and comfort.

After 16 years of growth and modernization, Executive Director Darren Gilmour steps down, leaving Canada's national academy at a pivotal crossroads.

With a fourfold revenue jump, China's Yangtze River Pharmaceutical Group isn't just selling drugs; it's exporting a new model of global trust and quality.

Amid surging recurring revenue and a booming cybersecurity market, Allot's leadership prepares to outline its ambitious growth strategy for 2026 to investors.

Aviatrix launches the first AI Containment Platform, declaring a new 'Containment Era' to tame autonomous agents and limit their potential blast radius.

A global alliance launches a $500M initiative to build the open data foundation for AI to predict biology and revolutionize medicine.

Beyond the trophies, an annual risk management conference reveals how top firms are tackling cyber threats, supply chain chaos, and the rise of AI.

Genomics' big data and Greywolf's novel drugs unite to develop first-in-class treatments for autoimmune diseases, promising a new era of precision medicine.

A landmark study reveals a hidden genetic cause for a common kidney disease in adults, urging for expanded genetic screening and paving the way for new therapies.

A landmark deal sees a major pharma manufacturer adopt Kneat Gx, signaling a pivotal shift towards digital automation and data integrity in life sciences.

Enterprises are spending trillions on AI, yet over 80% of projects fail to deliver value. The reason isn't technology—it's a critical lack of governance.

As AI transforms legal practice, Assembly Software hires a customer success veteran to ensure its high-growth technology delivers real-world results for firms.

Two lawful permanent residents detained by ICE are fighting back after the U.S. government revoked their status over disputed ties to a late Iranian general.

Massive Bio and OpenAI launch a groundbreaking AI initiative to automate patient matching for clinical trials, aiming to boost health equity and speed up research.

A partnership with Emapta helped mortgage lender AFN achieve a massive 300% funding increase, rewriting the rules on compliant offshore collaboration.

Beth Israel Lahey Health is fighting physician burnout by giving its 6,000 doctors an AI assistant, a move that could reshape patient care across New England.

As ad fraud costs exceed $120B, BrandPilot AI adds a key expert to its advisory board, signaling a renewed assault on invalid traffic and data distortion.

A new FDA-Paradigm Health partnership uses AI to review clinical trial data in real time, aiming to cut drug development costs and approval delays.

Qdrant adds GPU-accelerated indexing, multi-AZ clusters, and audit logs, tackling enterprise needs for AI performance, reliability, and compliance.

Neurogene bets on a direct-to-brain delivery method for its Rett syndrome gene therapy, arguing the established surgical technique offers superior results.